MediFind

Find a Doctor

Jingtao M. Dou

Chinese Pla General Hospital

Bio


Jingtao Dou is in Beijing, China. They have been an author on 59 peer reviewed articles in the past 15 years. Dr. Dou's top three areas of expertise are Type B Insulin Resistance Syndrome, Cushing Syndrome, and Type 2 Diabetes.

Contact

Beijing, CN

Latest Research


Latest Advance
Study
  • Condition: Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
  • Journal: Hepatology (Baltimore, Md.)
  • Treatment Used: Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin
  • Number of Patients: 0
  • Published —
In this study, researchers evaluated the effects of iraglutide, sitagliptin, or insulin glargine added to metformin on nonalcoholic fatty liver disease in patients with type 2 diabetes.
Latest Advance
Study
  • Condition: Type 2 diabetes
  • Journal: Diabetes, obesity & metabolism
  • Treatment Used: Saxagliptin plus metformin
  • Number of Patients: 630
  • Published —
This Chinese study evaluated the efficacy and safety of saxagliptin plus metformin in patients with type 2 diabetes and inadequate blood sugar control ( levels of Glycated hemoglobin HbA1c between 8% and 12%).

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Beijing, CN

Insurance

Contact them to find out if they accept your insurance plan.